3.60Open3.42Pre Close467 Volume1.35K Open Interest75.00Strike Price163.26KTurnover1635.93%IV0.32%PremiumNov 29, 2024Expiry Date2.99Intrinsic Value100Multiplier-1DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.9420Delta0.0581Gamma27.13Leverage Ratio-124.8136Theta0.0000Rho25.55Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet